Incretin and glucagon signalling in MASLD and MASH: integrating metabolic pathways with disease progression
Tsakiridis EE, Steinberg GR
Diabetes Obes Metab. Pub. online 12 Mar 2026.
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Challenging the consensus statement: is it time to recognise pharmacological remission of type 2 diabetes?
Bianchi C, Del Prato S, Rothberg AE, Nauck MA
Diabetes Obes Metab. Pub. online 19 Mar 2026.
Leggi
The burden of obesity and type 1 diabetes: distinct and synergistic effects to worsen perceived health and psychosocial distress
Risi R, Pauletto D, Zanghi Buffi V, et al.
Diabetes Obes Metab. Pub. online 9 Mar 2026.
Leggi
Early meal timing improves nocturnal glucose in pregnancies complicated by gestational diabetes
Cunningham HA, Ward L, Butler MP, Valent AM
Diabetologia. Pub. online 9 Mar 2026.
Leggi
Sex-specific differences in the prevalence of intermediate hyperglycaemia states: a systematic review and meta-analysis
Cooper L, Porter I, Meek C, et al.
Diabet Med. Pub. online 10 Mar 2026.
Leggi
Weight loss as a determinant of histological improvement in metabolic dysfunction-associated steatotic liver disease in people with obesity. A systematic review and network meta-analysis of randomised clinical trials
Monami M, Belluzzi A, Buscemi S, et al.
Diabetes Obes Metab. Pub. online 9 Mar 2026.
Leggi
Metabolic liver disease: a summary of major guidelines and identifying opportunities to improve future guidelines
Bril F
Diabetes Obes Metab. Pub. online 13 Mar 2026.
Leggi
Efficacy and safety of cagrilintide and cagrisema versus semaglutide as anti‐obesity medications: a systematic review, meta‐analysis and meta‐regression
Ahmed M, Hassan M, Tahir M, et al.
Diabetes Obes Metab. Pub. online 16 Mar 2026.
Leggi
Identifying predictors of early treatment intensification in individuals with type 2 diabetes treated with GLP-1 receptor agonists: a machine learning-based analysis of a large real world cohort
Falcetta P, Zilich R, Baccetti F, et al.
Diabetes Obes Metab. Pub. online 9 Mar 2026.
Leggi
Cardiovascular outcomes of GLP-1RA vs SGLT2i in MASLD and type 2 diabetes: real-world evidence
Yang CC, Wu JY, Cheng YY, et al.
Diabetes Res Clin Pract. Pub. online 7 Mar 2026.
Leggi